Skip to content

Cornea Preservation Time Study

Effect of Corneal Preservation Time on Long-Term Graft Success

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01537393
Acronym
CPTS
Enrollment
1174
Registered
2012-02-23
Start date
2012-04-16
Completion date
2017-06-30
Last updated
2018-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cornea Preservation Time, Endothelial Cell Density, Endothelial Keratoplasty, Transplant Success

Keywords

cornea, transplant, preservation, endothelial keratoplasty

Brief summary

The purpose of this study is to determine if the 3-year graft failure rate following endothelial keratoplasty performed with donor corneas with a preservation time of 8 to 14 days is non-inferior to the failure rate when donor corneas with a preservation time of 7 or fewer days are used.

Detailed description

When the donor cornea is removed from the person who died, it is prepared for transplantation by an eye bank. The donor cornea is placed into a liquid that helps preserve the cornea until it is transplanted. The Food and Drug Administration (FDA) has approved storage of the cornea in this liquid for up to 14 days before the transplant. The purpose of this study is to see if the length of time the donor cornea is kept in the preservation liquid before the transplant affects the likelihood of the transplant being successful. We will follow participants for 3 years after transplant to see if there are any differences in transplant success or in the number of transplanted endothelial cells (the layer of cells that line the undersurface of the cornea) on the corneas that were preserved for 7 days or less compared to those preserved between 8 and 14 days. We have no reason to believe that there is any greater risk for transplant failure with either preservation time group.

Interventions

BIOLOGICALCornea tissue transplant

Cornea tissue preserved 0 to 7 days

Sponsors

National Eye Institute (NEI)
CollaboratorNIH
Jaeb Center for Health Research
CollaboratorOTHER
Case Western Reserve University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
30 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Study Participant Eligibility Criteria * Study Participant Inclusion Criteria 1. Age range 30-\<91 years with minimum life expectancy of at least 3 years. 2. Willingness to return for follow-up study visits at 1 day, 1 week, 1 month, 6 months, 1 year, 2 years and 3 years. 3. Fluent in English or Spanish. * Study Participant

Exclusion criteria

1) Decisionally and/or cognitively impaired Study Eye Eligibility Criteria * Study Eye Inclusion Criteria 1. Endothelial keratoplasty (EK) is scheduled between 10 and 60 days after enrollment * The 10-day requirement relates to the need to be able to randomly assign the eye to either intervention group. * The 60-day requirement relates to the need to have current eligibility and enrollment data at the time of surgery. If surgery is postponed to \>60 days after the initial enrollment visit, a new Baseline Visit and eligibility assessment will have to be performed. 2. Presence of a condition related to endothelial dysfunction which will be treated by EK. * Eligible indications for EK include: * Presence of Fuchs endothelial corneal dystrophy (FECD) meeting at least one of the following: * Phakic FECD * Phakic FECD with cataract * Triple procedure including EK for FECD, cataract extraction and posterior chamber intraocular lens implantation (IOL) is allowed * Aphakic FECD * Pseudophakic FECD with posterior capsule supported, suture-fixated, or sulcus-supported posterior chamber IOL * Aphakic or pseudophakic corneal edema with posterior capsule supported, suture-fixated, or sulcus-supported posterior chamber IOL without FECD * Study Eye

Design outcomes

Primary

MeasureTime frameDescription
Number of Eyes With Corneal Graft Failure Within 3 Years of SurgeryStudy eye will be assessed for this outcome for 3 years following surgeryGraft failure, defined as the occurrence of one of the following within 3 years of surgery: * Regrafting of the study eye for any reason * Cornea which remains cloudy without clearing, according to the following: 1. cloudy cornea on the first postoperative day which does not clear within 8 weeks OR 2. cloudy cornea which was initially clear postoperatively but becomes and remains cloudy for 3 months without clearing.
Endothelial Cell Density (ECD)3 years from surgeryEndothelial cell density at 3 years from surgery, conditional on graft survival at 3 years from surgery.

Countries

United States

Participant flow

Pre-assignment details

Randomization was at eye level. When both eyes of a participant were included, the eye undergoing surgery 1st was assigned randomly to a PT group and the 2nd eye to the other group. 2 eyes had their assigned donor corneas inadvertently switched, and resulted in 1 of these participants receiving both study eyes from 8-14d group.

Participants by arm

ArmCount
Preservation Time Group 1
Subjects in this arm will receive cornea tissue preserved for up to 7 days prior to transplant. Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.
675
Preservation Time Group 1
Subjects in this arm will receive cornea tissue preserved for up to 7 days prior to transplant. Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.
675
Preservation Time Group 2
Subjects in this arm will receive cornea tissue preserved for 8 to 14 days prior to transplant. Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.
654
Preservation Time Group 2
Subjects in this arm will receive cornea tissue preserved for 8 to 14 days prior to transplant. Cornea tissue transplant: Cornea tissue preserved either 7 or less days or 8 to 14 days.
655
Total2,659

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyCensored (severe event unrelated to PT)11
Overall StudyDeath2032
Overall StudyExclude prior to study3244
Overall StudyFailure - Not regrafted26
Overall StudyFailure - Regrafted2843
Overall StudyLost to Follow-up5348
Overall StudyWithdrawal by Subject1817

Baseline characteristics

CharacteristicPreservation Time Group 2TotalPreservation Time Group 1
Age, Continuous70 years70 years70 years
Central subepithelial/stromal scarring present (not affect postoperative stromal clarity assessment)48 eyes85 eyes37 eyes
Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))
EBMD (epithelial basement membrane dystrophy)
29 eyes67 eyes38 eyes
Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))
Keratoconus
0 eyes1 eyes1 eyes
Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))
No
623 eyes1253 eyes630 eyes
Corneal Dystrophy other than FECD (Fuchs endothelial corneal dystrophy))
Other
3 eyes9 eyes6 eyes
Current cigarette smoker45 eyes90 eyes45 eyes
Diagnosis
Aphakic corneal edema without FECD
2 eyes2 eyes0 eyes
Diagnosis
Fuchs endothelial corneal dystrophy (FECD)
624 eyes1255 eyes631 eyes
Diagnosis
Pseudophakic corneal edema without FECD
29 eyes73 eyes44 eyes
Glaucoma medication currently being used54 eyes99 eyes45 eyes
History of Diabetes126 eyes242 eyes116 eyes
Intraocular pressure (IOP)15 mm Hg15 mm Hg15 mm Hg
Peripheral anterior synechiae present (nongonioscopic)2 eyes6 eyes4 eyes
Postoperative lens status
Phakic
6 eyes10 eyes4 eyes
Postoperative lens status
Pseudophakic posterior chamber intraocular lens
649 eyes1320 eyes671 eyes
Preoperative lens status
Aphakic
2 eyes2 eyes0 eyes
Preoperative lens status
Phakic
351 eyes692 eyes341 eyes
Preoperative lens status
Pseudophakic posterior chamber intraocular lens
302 eyes636 eyes334 eyes
Prior glaucoma surgery13 eyes31 eyes18 eyes
Race/Ethnicity, Customized
African American
21 eyes47 eyes26 eyes
Race/Ethnicity, Customized
American India or Alaskan Native
2 eyes3 eyes1 eyes
Race/Ethnicity, Customized
Asian
5 eyes12 eyes7 eyes
Race/Ethnicity, Customized
Hispanic or Latino
25 eyes44 eyes19 eyes
Race/Ethnicity, Customized
More than 1 race
3 eyes9 eyes6 eyes
Race/Ethnicity, Customized
Unknown or not reported
5 eyes8 eyes3 eyes
Race/Ethnicity, Customized
White
594 eyes1207 eyes613 eyes
Received any immunizations or vaccinations in last 3 mo81 eyes173 eyes92 eyes
Sex: Female, Male
Female
392 eyes801 eyes409 eyes
Sex: Female, Male
Male
263 eyes529 eyes266 eyes
Stromal corneal vessels present (but not visually significant)1 eyes5 eyes4 eyes

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
20 / 67532 / 654
other
Total, other adverse events
0 / 6750 / 654
serious
Total, serious adverse events
1 / 6752 / 654

Outcome results

Primary

Endothelial Cell Density (ECD)

Endothelial cell density at 3 years from surgery, conditional on graft survival at 3 years from surgery.

Time frame: 3 years from surgery

Population: Eyes with graft success and a gradable image at 3 year (945 eyes of 769 unique participants)

ArmMeasureValue (MEAN)Dispersion
Preservation Time Group 1Endothelial Cell Density (ECD)1722 Cells per square millimeterStandard Deviation 626
Preservation Time Group 2Endothelial Cell Density (ECD)1642 Cells per square millimeterStandard Deviation 631
p-value: 0.0395% CI: [8, 138]Mixed Models Analysis
Primary

Number of Eyes With Corneal Graft Failure Within 3 Years of Surgery

Graft failure, defined as the occurrence of one of the following within 3 years of surgery: * Regrafting of the study eye for any reason * Cornea which remains cloudy without clearing, according to the following: 1. cloudy cornea on the first postoperative day which does not clear within 8 weeks OR 2. cloudy cornea which was initially clear postoperatively but becomes and remains cloudy for 3 months without clearing.

Time frame: Study eye will be assessed for this outcome for 3 years following surgery

Population: Analyzed number of eyes in each group (Overall 1090 unique participants)

ArmMeasureValue (COUNT_OF_UNITS)
Preservation Time Group 1Number of Eyes With Corneal Graft Failure Within 3 Years of Surgery30 Eyes
Preservation Time Group 2Number of Eyes With Corneal Graft Failure Within 3 Years of Surgery49 Eyes
p-value: 0.0295% CI: [1.09, 2.71]Regression, Cox

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026